Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, et al.
2011-12-01 • PLOS One
2011-12-01 • PLOS One
India carries one quarter of the global burden of multi-drug resistant TB (MDR-TB) and has an estimated 2.5 million people living with HIV. Despite this reality, provision of treatment f...
Ardizzoni E, Fajardo E, Saranchuk P, Casenghi M, Page AL, et al.
2015-12-15 • PLOS One
2015-12-15 • PLOS One
BACKGROUND The Xpert® MTB/RIF (Xpert) is an automated molecular test for simultaneous detection of tuberculosis (TB) and rifampicin resistance, recommended by the World Health Organi...
AIDS-related CMV retinitis is a common clinical problem in patients with advanced HIV/AIDS in China and Southeast Asia. The disease is causing blindness, and current clinical management,...
Moon S, Van Leemput L, Durier N, Jambert E, Dahmane A, et al.
2008-09-01 • AIDS Care
2008-09-01 • AIDS Care
Financial access to HIV care and treatment can be difficult for many people in China, where the government provides free antiretroviral drugs but does not cover the cost of other medical...
Saranchuk P, Boulle AM, Hilderbrand K, Coetzee D, Bedelu M, et al.
2007-07-01 • South African Medical Journal
2007-07-01 • South African Medical Journal
OBJECTIVES: To evaluate the diagnostic accuracy of and reduction in diagnostic delay attributable to a clinical algorithm used for the diagnosis of smear-negative pulmonary tuberculosis ...
Das M, Andries A, Deshpande A, Mansoor H, Saranchuk P, et al.
2014-07-30 • Global Health Action
2014-07-30 • Global Health Action
There are limited data on the failure of second-line antiretroviral therapy (ART) and the use of third-line ART in people living with HIV in resource-limited settings. Since 2011, the Mé...
Albuquerque T, Isaakidis P, Das M, Saranchuk P, Andries A, et al.
2014-03-21 • Public Health Action
2014-03-21 • Public Health Action
Background: Mumbai has a population of 21 million, and an increasingly recognised epidemic of drug-resistant tuberculosis (DR-TB). Objective: To describe TB infection control (IC) measur...
Das M, Isaakidis P, Shenoy R, Anicete R, Sharma H, et al.
2014-09-26 • PLOS One
2014-09-26 • PLOS One
Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' are...
The prevalence and the patterns of ocular inflammatory disease and ocular tuberculosis (TB) are largely undocumented among Multidrug Resistant TB (MDR-TB) patients co-infected with Human...
Heiden D, Tun NL, Maningding E, Heiden M, Rose-Nussbaumer J, et al.
2014-09-22 • Bulletin of the World Health Organization
2014-09-22 • Bulletin of the World Health Organization
PROBLEM Acquired immunodeficiency syndrome (AIDS)-related cytomegalovirus (CMV) retinitis continues to be a neglected source of blindness in resource-poor settings. The main issue is...
Ford NP, Shubber Z, Saranchuk P, Pathai S, Durier N, et al.
2013-07-29 • Clinical Infectious Diseases
2013-07-29 • Clinical Infectious Diseases
BACKGROUND Cytomegalovirus (CMV) is a late-stage opportunistic infection in people living with human immunodeficiency virus (HIV)/AIDS. Lack of ophthalmological diagnostic skills, la...
Dalal A, Pawaskar A, Das M, Desari R, Prabhudesai P, et al.
2015-01-21 • PLOS One
2015-01-21 • PLOS One
While the high burden of multidrug-resistant tuberculosis (MDR-TB) itself is a matter of great concern, the emergence and rise of advanced forms of drug-resistance such as extensively dr...
Cohen RM, Lynch S, Bygrave H, Eggers E, Vlahakis N, et al.
2009-10-08 • Journal of the International AIDS Society
2009-10-08 • Journal of the International AIDS Society
ABSTRACT: INTRODUCTION: Lesotho has the third highest HIV prevalence in the world (an adult prevalence of 23.2%). Despite a lack of resources for health, the country has implemented stat...
BACKGROUND The second-line anti-tuberculosis drugs used in the treatment of multidrug-resistant tuberculosis often cause adverse events, especially in patients co-infected with the h...
Isaakidis P, Das M, Kumar AMV, Peskett C, Khetarpal M, et al.
2014-10-21 • PLOS One
2014-10-21 • PLOS One
Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, no countrywide prevalence data are available. The burden of DR-TB in HIV-co-infected pa...
